BioCentury
ARTICLE | Company News

Novartis sales and marketing update

August 22, 2016 7:00 AM UTC

The U.K.’s NICE issued draft guidance recommending against the use of Afinitor everolimus because it “did not have plausible potential to be cost effective,” even when offered an undisclosed discount...